Franklin Biolabs, a new genetic medicines contract research organization (CRO), will be the services and production arm, providing comprehensive solutions from discovery to development and distribution for the global genetic medicines industry.
Alongside GEMMABio, Franklin Biolabs will advance cell & gene therapy research and deliver therapeutics to patients around the world significantly faster.
Company Details
- Employees
- 94
- Founded
- -
- Address
- 411 Swedeland Rd, King Of Prussia,pennsylvania 19406,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.franklinbio.com/
- Keywords
- Rare Disease, RNA-seq, Single-cell analysis, indel analysis, Next generation sequencing, Manufacturing Process development, Preclinical vector production, Mass spectrometry, GMP manufacturing, Histology, Biodistribution, Toxicology Studies, Pharmacology Studies, B-Cell Assays, T-Cell Assays, In situ hybridization, electron microscopy, Fluorescence and brightfield microscopy, Analytics, Gene Therapy.
- HQ
- King of Prussia, Pennsylvania
Franklin Biolabs Questions
Franklin Biolabs's website is https://www.franklinbio.com/
Franklin Biolabs's LinkedIn profile is https://www.linkedin.com/company/franklinbio
Franklin Biolabs has
94 employees.
View email and phone details for 94
employees at Franklin Biolabs.
Franklin Biolabs's industry is
Biotechnology Research
Franklin Biolabs's top competitors are
Passage Bio,
Gene Therapy Program | University Of Pennsylvania,
Iovance Biotherapeutics, Inc.,
Gemma Biotherapeutics,
Bioculture Group,
Interius Biotherapeutics,
Legend Biotech,
Sk Pharmteco,
Tolerance Bio,
Spark Therapeutics, Inc..
Franklin Biolabs's categories are Biotechnology Research
Franklin Biolabs's founding year is 2024
